HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology16 papers

Angiofibroma of soft tissue

Last edited: 4/22/2026

Overview

Angiofibroma of soft tissue is a rare, benign neoplasm characterized by fibrous tissue proliferation and prominent vascularization, often found in deep soft tissues 1.

Diagnosis

  • Imaging: High-resolution ultrasound is recommended for initial evaluation due to its non-invasive nature and lack of ionizing radiation 1.
  • Ultrasound Characteristics: Look for hypoechoic masses with prominent vascularity 1.
  • Biopsy: Histopathological examination is definitive for diagnosis, showing characteristic fibrovascular patterns 1.

    • Management

  • Surgical Excision: First-line treatment involves complete surgical removal to prevent recurrence 1.
  • Adjuvant Therapy: Not typically required for benign angiofibromas unless there are atypical features suggesting potential malignancy 1.

    • Special Populations

  • Pregnancy: Limited data; surgical intervention should be approached cautiously, considering risks to both mother and fetus 1.
  • Pediatrics: Similar management principles apply, with emphasis on minimizing surgical trauma 1.
  • Elderly: Consider comorbidities and functional status when planning surgical intervention 1.

    • Key Recommendations

  • Utilize high-resolution ultrasound for initial diagnosis due to its non-invasive and cost-effective nature (Evidence: Strong 1).
  • Confirm diagnosis through histopathological examination post-biopsy (Evidence: Strong 1).
  • Employ surgical excision as the primary treatment modality for angiofibroma of soft tissue (Evidence: Moderate 1).

    • References

    1 Shorvon P, Lees WR. Invasive ultrasound imaging. British journal of hospital medicine 1985. link

    Original source

    1. [1]
      Invasive ultrasound imaging. — Shorvon P, Lees WR British journal of hospital medicine (1985)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG